CA2902841A1 - Methods and compositions for detecting pancreatic cancer - Google Patents

Info

Publication number

CA2902841A1

CA2902841A1 CA2902841A CA2902841A CA2902841A1 CA 2902841 A1 CA2902841 A1 CA 2902841A1 CA 2902841 A CA2902841 A CA 2902841A CA 2902841 A CA2902841 A CA 2902841A CA 2902841 A1 CA2902841 A1 CA 2902841A1

Authority

CA

Canada

Prior art keywords

pancreatic cancer

protein

level

cancer biomarker

homo sapiens

Prior art date

2013-03-13

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 206010061902 Pancreatic neoplasm Diseases 0.000 title claims abstract description 511
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 title claims abstract description 510
• 201000002528 pancreatic cancer Diseases 0.000 title claims abstract description 510
• 208000008443 pancreatic carcinoma Diseases 0.000 title claims abstract description 510
• 238000000034 method Methods 0.000 title claims abstract description 225
• 239000000203 mixture Substances 0.000 title abstract description 47
• 239000000107 tumor biomarker Substances 0.000 claims abstract description 368
• 241000282414 Homo sapiens Species 0.000 claims description 351
• 108090000623 proteins and genes Proteins 0.000 claims description 269
• 102000004169 proteins and genes Human genes 0.000 claims description 266
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 232
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 197
• 239000000523 sample Substances 0.000 claims description 181
• 229920001184 polypeptide Polymers 0.000 claims description 163
• 239000012530 fluid Substances 0.000 claims description 150
• 239000012634 fragment Substances 0.000 claims description 111
• 230000002496 gastric effect Effects 0.000 claims description 101
• 206010028980 Neoplasm Diseases 0.000 claims description 72
• 239000013068 control sample Substances 0.000 claims description 72
• 201000008129 pancreatic ductal adenocarcinoma Diseases 0.000 claims description 52
• 239000003795 chemical substances by application Substances 0.000 claims description 47
• 150000007523 nucleic acids Chemical class 0.000 claims description 47
• 102000039446 nucleic acids Human genes 0.000 claims description 46
• 108020004707 nucleic acids Proteins 0.000 claims description 46
• 238000004949 mass spectrometry Methods 0.000 claims description 42
• 229920001223 polyethylene glycol Polymers 0.000 claims description 42
• 125000003729 nucleotide group Chemical group 0.000 claims description 40
• 238000012360 testing method Methods 0.000 claims description 39
• 239000002773 nucleotide Substances 0.000 claims description 38
• 238000003556 assay Methods 0.000 claims description 36
• 210000001035 gastrointestinal tract Anatomy 0.000 claims description 34
• 210000000496 pancreas Anatomy 0.000 claims description 33
• 229960005336 magnesium citrate Drugs 0.000 claims description 32
• 235000002538 magnesium citrate Nutrition 0.000 claims description 32
• 239000004337 magnesium citrate Substances 0.000 claims description 32
• PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 32
• 238000009739 binding Methods 0.000 claims description 29
• 239000002202 Polyethylene glycol Substances 0.000 claims description 28
• 230000027455 binding Effects 0.000 claims description 28
• 102000004190 Enzymes Human genes 0.000 claims description 27
• 108090000790 Enzymes Proteins 0.000 claims description 27
• 238000003018 immunoassay Methods 0.000 claims description 26
• INZOTETZQBPBCE-NYLDSJSYSA-N 3-sialyl lewis Chemical group O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@H](O)CO)[C@@H]([C@@H](NC(C)=O)C=O)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 INZOTETZQBPBCE-NYLDSJSYSA-N 0.000 claims description 24
• 239000007787 solid Substances 0.000 claims description 23
• 238000011282 treatment Methods 0.000 claims description 22
• 239000007790 solid phase Substances 0.000 claims description 20
• 239000000427 antigen Substances 0.000 claims description 19
• 108091007433 antigens Proteins 0.000 claims description 19
• 102000036639 antigens Human genes 0.000 claims description 19
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 17
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 14
• RGPGEMGZZATIQL-UHFFFAOYSA-H magnesium;dipotassium;disodium;trisulfate Chemical compound [Na+].[Na+].[Mg+2].[K+].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RGPGEMGZZATIQL-UHFFFAOYSA-H 0.000 claims description 13
• 238000003127 radioimmunoassay Methods 0.000 claims description 13
• 238000001262 western blot Methods 0.000 claims description 11
• -1 NULYTELY Chemical compound 0.000 claims description 10
• KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 claims description 9
• 229960000503 bisacodyl Drugs 0.000 claims description 9
• 229910052938 sodium sulfate Inorganic materials 0.000 claims description 9
• 235000011152 sodium sulphate Nutrition 0.000 claims description 9
• 208000001976 Endocrine Gland Neoplasms Diseases 0.000 claims description 8
• 201000011523 endocrine gland cancer Diseases 0.000 claims description 8
• 229940056944 golytely Drugs 0.000 claims description 8
• 230000003248 secreting effect Effects 0.000 claims description 8
• HFDKKNHCYWNNNQ-YOGANYHLSA-N 75976-10-2 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C1=CC=C(O)C=C1 HFDKKNHCYWNNNQ-YOGANYHLSA-N 0.000 claims description 7
• 102000018886 Pancreatic Polypeptide Human genes 0.000 claims description 7
• 101000983124 Sus scrofa Pancreatic prohormone precursor Proteins 0.000 claims description 7
• 235000010323 ascorbic acid Nutrition 0.000 claims description 7
• 229960005070 ascorbic acid Drugs 0.000 claims description 7
• 239000011668 ascorbic acid Substances 0.000 claims description 7
• 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 7
• 229960003390 magnesium sulfate Drugs 0.000 claims description 7
• 235000019341 magnesium sulphate Nutrition 0.000 claims description 7
• 230000009996 pancreatic endocrine effect Effects 0.000 claims description 7
• OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 7
• 229910052939 potassium sulfate Inorganic materials 0.000 claims description 7
• 235000011151 potassium sulphates Nutrition 0.000 claims description 7
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 7
• 208000008999 Giant Cell Carcinoma Diseases 0.000 claims description 6
• 206010018404 Glucagonoma Diseases 0.000 claims description 6
• 206010041329 Somatostatinoma Diseases 0.000 claims description 6
• 208000009311 VIPoma Diseases 0.000 claims description 6
• 208000006336 acinar cell carcinoma Diseases 0.000 claims description 6
• 201000008395 adenosquamous carcinoma Diseases 0.000 claims description 6
• 238000007398 colorimetric assay Methods 0.000 claims description 6
• 208000012106 cystic neoplasm Diseases 0.000 claims description 6
• 230000002550 fecal effect Effects 0.000 claims description 6
• 201000000052 gastrinoma Diseases 0.000 claims description 6
• 239000004615 ingredient Substances 0.000 claims description 6
• 206010022498 insulinoma Diseases 0.000 claims description 6
• 201000000014 lung giant cell carcinoma Diseases 0.000 claims description 6
• 229940118092 nulytely Drugs 0.000 claims description 6
• 238000010926 purge Methods 0.000 claims description 6
• 229960005077 sodium picosulfate Drugs 0.000 claims description 6
• GOZDTZWAMGHLDY-UHFFFAOYSA-L sodium picosulfate Chemical compound [Na+].[Na+].C1=CC(OS(=O)(=O)[O-])=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS([O-])(=O)=O)C=C1 GOZDTZWAMGHLDY-UHFFFAOYSA-L 0.000 claims description 6
• 206010041823 squamous cell carcinoma Diseases 0.000 claims description 6
• 210000005095 gastrointestinal system Anatomy 0.000 claims description 5
• 238000012544 monitoring process Methods 0.000 claims description 5
• 201000002530 pancreatic endocrine carcinoma Diseases 0.000 claims description 5
• 229940093914 potassium sulfate Drugs 0.000 claims description 5
• 208000000649 small cell carcinoma Diseases 0.000 claims description 5
• 229960003010 sodium sulfate Drugs 0.000 claims description 5
• 125000003275 alpha amino acid group Chemical group 0.000 claims 16
• 238000003745 diagnosis Methods 0.000 abstract description 5
• 238000004393 prognosis Methods 0.000 abstract description 4
• 235000018102 proteins Nutrition 0.000 description 241
• 239000002243 precursor Substances 0.000 description 170
• 102000001708 Protein Isoforms Human genes 0.000 description 105
• 108010029485 Protein Isoforms Proteins 0.000 description 103
• 201000011510 cancer Diseases 0.000 description 55
• 150000001413 amino acids Chemical group 0.000 description 38
• 210000004027 cell Anatomy 0.000 description 38
• 239000011230 binding agent Substances 0.000 description 29
• 238000001514 detection method Methods 0.000 description 28
• 229940088598 enzyme Drugs 0.000 description 25
• 238000004458 analytical method Methods 0.000 description 20
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
• 102100025566 Chymotrypsin-like protease CTRL-1 Human genes 0.000 description 17
• 101000856199 Homo sapiens Chymotrypsin-like protease CTRL-1 Proteins 0.000 description 17
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
• 239000003153 chemical reaction reagent Substances 0.000 description 15
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
• 230000009870 specific binding Effects 0.000 description 15
• 210000001519 tissue Anatomy 0.000 description 15
• 210000003608 fece Anatomy 0.000 description 14
• 230000000968 intestinal effect Effects 0.000 description 13
• 108090001060 Lipase Proteins 0.000 description 12
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
• 102000013035 dynein heavy chain Human genes 0.000 description 12
• 108060002430 dynein heavy chain Proteins 0.000 description 12
• 125000006853 reporter group Chemical group 0.000 description 12
• 102000004882 Lipase Human genes 0.000 description 11
• 239000004367 Lipase Substances 0.000 description 11
• 201000010099 disease Diseases 0.000 description 11
• 229940040461 lipase Drugs 0.000 description 11
• 235000019421 lipase Nutrition 0.000 description 11
• 239000002904 solvent Substances 0.000 description 11
• 238000002965 ELISA Methods 0.000 description 10
• 102000042654 Elastase family Human genes 0.000 description 10
• 108091075465 Elastase family Proteins 0.000 description 10
• 239000012528 membrane Substances 0.000 description 10
• 210000004379 membrane Anatomy 0.000 description 10
• 210000000056 organ Anatomy 0.000 description 10
• 238000002360 preparation method Methods 0.000 description 10
• 238000001356 surgical procedure Methods 0.000 description 10
• 238000004885 tandem mass spectrometry Methods 0.000 description 10
• 239000013060 biological fluid Substances 0.000 description 9
• 238000002052 colonoscopy Methods 0.000 description 9
• 239000008141 laxative Substances 0.000 description 9
• 239000000243 solution Substances 0.000 description 9
• 102100033407 Alpha-amylase 2B Human genes 0.000 description 8
• 101710082073 Alpha-amylase 2B Proteins 0.000 description 8
• 239000004382 Amylase Substances 0.000 description 8
• 102000013142 Amylases Human genes 0.000 description 8
• 108010065511 Amylases Proteins 0.000 description 8
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
• 206010011732 Cyst Diseases 0.000 description 8
• 235000019418 amylase Nutrition 0.000 description 8
• 210000004369 blood Anatomy 0.000 description 8
• 239000008280 blood Substances 0.000 description 8
• 208000031513 cyst Diseases 0.000 description 8
• 239000008151 electrolyte solution Substances 0.000 description 8
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
• 102000005962 receptors Human genes 0.000 description 8
• 108020003175 receptors Proteins 0.000 description 8
• 108090000087 Carboxypeptidase B Proteins 0.000 description 7
• 102000003670 Carboxypeptidase B Human genes 0.000 description 7
• 102000005367 Carboxypeptidases Human genes 0.000 description 7
• 108010006303 Carboxypeptidases Proteins 0.000 description 7
• 108020004414 DNA Proteins 0.000 description 7
• 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 7
• 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 7
• 108010067372 Pancreatic elastase Proteins 0.000 description 7
• 102000016387 Pancreatic elastase Human genes 0.000 description 7
• 239000012472 biological sample Substances 0.000 description 7
• 230000003247 decreasing effect Effects 0.000 description 7
• 150000002500 ions Chemical class 0.000 description 7
• 239000011159 matrix material Substances 0.000 description 7
• 230000002829 reductive effect Effects 0.000 description 7
• 239000000126 substance Substances 0.000 description 7
• 102000004506 Blood Proteins Human genes 0.000 description 6
• 108010017384 Blood Proteins Proteins 0.000 description 6
• 102100024295 Maltase-glucoamylase Human genes 0.000 description 6
• 102100033359 Pancreatic triacylglycerol lipase Human genes 0.000 description 6
• 101710162333 Pancreatic triacylglycerol lipase Proteins 0.000 description 6
• 102100032491 Serine protease 1 Human genes 0.000 description 6
• 101710151387 Serine protease 1 Proteins 0.000 description 6
• 101710119665 Trypsin-1 Proteins 0.000 description 6
• 108010028144 alpha-Glucosidases Proteins 0.000 description 6
• 239000000090 biomarker Substances 0.000 description 6
• 230000008859 change Effects 0.000 description 6
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
• 210000000936 intestine Anatomy 0.000 description 6
• 230000002475 laxative effect Effects 0.000 description 6
• 239000010410 layer Substances 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 239000002953 phosphate buffered saline Substances 0.000 description 6
• 239000003826 tablet Substances 0.000 description 6
• 101710165037 Alpha-amylase 1 Proteins 0.000 description 5
• 102100033770 Alpha-amylase 1C Human genes 0.000 description 5
• 108010049777 Ankyrins Proteins 0.000 description 5
• 102000008102 Ankyrins Human genes 0.000 description 5
• 102000000905 Cadherin Human genes 0.000 description 5
• 108050007957 Cadherin Proteins 0.000 description 5
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
• 102100034392 Trypsin-2 Human genes 0.000 description 5
• 101710119666 Trypsin-2 Proteins 0.000 description 5
• 235000001014 amino acid Nutrition 0.000 description 5
• 238000010171 animal model Methods 0.000 description 5
• 238000013459 approach Methods 0.000 description 5
• 238000004587 chromatography analysis Methods 0.000 description 5
• 238000001360 collision-induced dissociation Methods 0.000 description 5
• 230000000875 corresponding effect Effects 0.000 description 5
• 238000002347 injection Methods 0.000 description 5
• 239000007924 injection Substances 0.000 description 5
• 238000005040 ion trap Methods 0.000 description 5
• 238000002372 labelling Methods 0.000 description 5
• 239000007788 liquid Substances 0.000 description 5
• 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 108020004999 messenger RNA Proteins 0.000 description 5
• 210000001819 pancreatic juice Anatomy 0.000 description 5
• 239000008188 pellet Substances 0.000 description 5
• 238000012545 processing Methods 0.000 description 5
• 210000002966 serum Anatomy 0.000 description 5
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
• 108091006146 Channels Proteins 0.000 description 4
• 108010016918 Histone-Lysine N-Methyltransferase Proteins 0.000 description 4
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
• 229910019142 PO4 Inorganic materials 0.000 description 4
• 102000007079 Peptide Fragments Human genes 0.000 description 4
• 108010033276 Peptide Fragments Proteins 0.000 description 4
• 108010071390 Serum Albumin Proteins 0.000 description 4
• 102000007562 Serum Albumin Human genes 0.000 description 4
• 102100027172 Transposon Hsmar1 transposase Human genes 0.000 description 4
• 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 4
• 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 4
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 4
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 4
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 4
• 238000000540 analysis of variance Methods 0.000 description 4
• 239000003593 chromogenic compound Substances 0.000 description 4
• 238000002405 diagnostic procedure Methods 0.000 description 4
• 208000035475 disorder Diseases 0.000 description 4
• 238000000605 extraction Methods 0.000 description 4
• 235000019253 formic acid Nutrition 0.000 description 4
• 238000004128 high performance liquid chromatography Methods 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 230000000155 isotopic effect Effects 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 238000004811 liquid chromatography Methods 0.000 description 4
• 230000003211 malignant effect Effects 0.000 description 4
• 230000003204 osmotic effect Effects 0.000 description 4
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 4
• 239000000047 product Substances 0.000 description 4
• 230000025220 protein targeting to vacuole Effects 0.000 description 4
• 210000003079 salivary gland Anatomy 0.000 description 4
• 238000001228 spectrum Methods 0.000 description 4
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 4
• 239000012588 trypsin Substances 0.000 description 4
• 238000005406 washing Methods 0.000 description 4
• LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 3
• QZDDFQLIQRYMBV-UHFFFAOYSA-N 2-[3-nitro-2-(2-nitrophenyl)-4-oxochromen-8-yl]acetic acid Chemical compound OC(=O)CC1=CC=CC(C(C=2[N+]([O-])=O)=O)=C1OC=2C1=CC=CC=C1[N+]([O-])=O QZDDFQLIQRYMBV-UHFFFAOYSA-N 0.000 description 3
• 102000009027 Albumins Human genes 0.000 description 3
• 108010088751 Albumins Proteins 0.000 description 3
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• 102100022749 Aminopeptidase N Human genes 0.000 description 3
• 108010049990 CD13 Antigens Proteins 0.000 description 3
• 108010080937 Carboxypeptidases A Proteins 0.000 description 3
• 102000000496 Carboxypeptidases A Human genes 0.000 description 3
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 3
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 3
• 239000010369 Cascara Substances 0.000 description 3
• 108090000205 Chymotrypsin C Proteins 0.000 description 3
• 102100039511 Chymotrypsin-C Human genes 0.000 description 3
• 102100023335 Chymotrypsin-like elastase family member 2A Human genes 0.000 description 3
• 101710149623 Chymotrypsin-like elastase family member 2A Proteins 0.000 description 3
• 102100039501 Chymotrypsinogen B Human genes 0.000 description 3
• 102100023755 Coiled-coil domain-containing protein 192 Human genes 0.000 description 3
• 102000008186 Collagen Human genes 0.000 description 3
• 108010035532 Collagen Proteins 0.000 description 3
• 102000012432 Collagen Type V Human genes 0.000 description 3
• 108010022514 Collagen Type V Proteins 0.000 description 3
• 108010002947 Connectin Proteins 0.000 description 3
• LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 3
• 101710088194 Dehydrogenase Proteins 0.000 description 3
• 241000556215 Frangula purshiana Species 0.000 description 3
• 101000978235 Homo sapiens Coiled-coil domain-containing protein 192 Proteins 0.000 description 3
• 102000004877 Insulin Human genes 0.000 description 3
• 108090001061 Insulin Proteins 0.000 description 3
• 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 3
• 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 3
• 102100034263 Mucin-2 Human genes 0.000 description 3
• 108010008705 Mucin-2 Proteins 0.000 description 3
• 108010026867 Oligo-1,6-Glucosidase Proteins 0.000 description 3
• 108091034117 Oligonucleotide Proteins 0.000 description 3
• 102000035195 Peptidases Human genes 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 238000000692 Student's t-test Methods 0.000 description 3
• 102100027918 Sucrase-isomaltase, intestinal Human genes 0.000 description 3
• 102100026260 Titin Human genes 0.000 description 3
• 101710159648 Uncharacterized protein Proteins 0.000 description 3
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 239000011575 calcium Substances 0.000 description 3
• 229910052791 calcium Inorganic materials 0.000 description 3
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 229920001436 collagen Polymers 0.000 description 3
• 230000000295 complement effect Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 239000003814 drug Substances 0.000 description 3
• 210000001198 duodenum Anatomy 0.000 description 3
• 239000003792 electrolyte Substances 0.000 description 3
• 238000001962 electrophoresis Methods 0.000 description 3
• 238000000132 electrospray ionisation Methods 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 230000022244 formylation Effects 0.000 description 3
• 238000006170 formylation reaction Methods 0.000 description 3
• 230000013595 glycosylation Effects 0.000 description 3
• 238000006206 glycosylation reaction Methods 0.000 description 3
• 229940125396 insulin Drugs 0.000 description 3
• 210000004153 islets of langerhan Anatomy 0.000 description 3
• 229940125722 laxative agent Drugs 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 229910052751 metal Inorganic materials 0.000 description 3
• 239000002184 metal Substances 0.000 description 3
• 210000003097 mucus Anatomy 0.000 description 3
• 210000000277 pancreatic duct Anatomy 0.000 description 3
• 239000013610 patient sample Substances 0.000 description 3
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
• 235000021317 phosphate Nutrition 0.000 description 3
• 239000010452 phosphate Chemical class 0.000 description 3
• 230000026731 phosphorylation Effects 0.000 description 3
• 238000006366 phosphorylation reaction Methods 0.000 description 3
• 210000002381 plasma Anatomy 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• 238000001556 precipitation Methods 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 239000013615 primer Substances 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 230000035755 proliferation Effects 0.000 description 3
• 230000005855 radiation Effects 0.000 description 3
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• 238000001179 sorption measurement Methods 0.000 description 3
• 238000004611 spectroscopical analysis Methods 0.000 description 3
• DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 3
• 239000002753 trypsin inhibitor Substances 0.000 description 3
• 210000002700 urine Anatomy 0.000 description 3
• 229910052725 zinc Inorganic materials 0.000 description 3
• 239000011701 zinc Substances 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
• UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
• 208000003200 Adenoma Diseases 0.000 description 2
• 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 2
• 102100040202 Apolipoprotein B-100 Human genes 0.000 description 2
• 108010008150 Apolipoprotein B-100 Proteins 0.000 description 2
• 206010003445 Ascites Diseases 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 102100035687 Bile salt-activated lipase Human genes 0.000 description 2
• 101710130200 Bile salt-activated lipase Proteins 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 108010008629 CA-125 Antigen Proteins 0.000 description 2
• 101700006667 CA1 Proteins 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 102100025518 Carbonic anhydrase 1 Human genes 0.000 description 2
• 102100023337 Chymotrypsin-like elastase family member 3A Human genes 0.000 description 2
• 101710149660 Chymotrypsin-like elastase family member 3A Proteins 0.000 description 2
• 101710147853 Chymotrypsinogen B Proteins 0.000 description 2
• 102000002734 Collagen Type VI Human genes 0.000 description 2
• 108010043741 Collagen Type VI Proteins 0.000 description 2
• 102000004420 Creatine Kinase Human genes 0.000 description 2
• 108010042126 Creatine kinase Proteins 0.000 description 2
• 102100037147 Cytoplasmic dynein 2 heavy chain 1 Human genes 0.000 description 2
• 108050000779 Cytoplasmic dynein 2 heavy chain 1 Proteins 0.000 description 2
• 206010012735 Diarrhoea Diseases 0.000 description 2
• 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 description 2
• 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 2
• 206010061818 Disease progression Diseases 0.000 description 2
• 102100032249 Dystonin Human genes 0.000 description 2
• 108010013976 Dystonin Proteins 0.000 description 2
• 102100030011 Endoribonuclease Human genes 0.000 description 2
• 101710199605 Endoribonuclease Proteins 0.000 description 2
• 102100029727 Enteropeptidase Human genes 0.000 description 2
• 108010013369 Enteropeptidase Proteins 0.000 description 2
• 102100037122 Extracellular matrix organizing protein FRAS1 Human genes 0.000 description 2
• 102400000321 Glucagon Human genes 0.000 description 2
• 108060003199 Glucagon Proteins 0.000 description 2
• 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 2
• 102100031132 Glucose-6-phosphate isomerase Human genes 0.000 description 2
• 102100028887 Hemicentin-2 Human genes 0.000 description 2
• 101710142179 Hemicentin-2 Proteins 0.000 description 2
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
• 102100027768 Histone-lysine N-methyltransferase 2D Human genes 0.000 description 2
• 101001029168 Homo sapiens Extracellular matrix organizing protein FRAS1 Proteins 0.000 description 2
• 101001045848 Homo sapiens Histone-lysine N-methyltransferase 2B Proteins 0.000 description 2
• 101001008894 Homo sapiens Histone-lysine N-methyltransferase 2D Proteins 0.000 description 2
• 101001047625 Homo sapiens Immunoglobulin kappa variable 2-40 Proteins 0.000 description 2
• 101000576901 Homo sapiens Serine/threonine-protein kinase MRCK alpha Proteins 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 101710158469 Ig mu chain C region Proteins 0.000 description 2
• 108060003951 Immunoglobulin Proteins 0.000 description 2
• 102100039352 Immunoglobulin heavy constant mu Human genes 0.000 description 2
• 102100022948 Immunoglobulin kappa variable 2-40 Human genes 0.000 description 2
• 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 2
• 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 2
• 206010073365 Intraductal papillary mucinous carcinoma of pancreas Diseases 0.000 description 2
• 108010001831 LDL receptors Proteins 0.000 description 2
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 238000000585 Mann–Whitney U test Methods 0.000 description 2
• 102100030882 Meprin A subunit alpha Human genes 0.000 description 2
• 101710090406 Meprin A subunit alpha Proteins 0.000 description 2
• 102100030876 Meprin A subunit beta Human genes 0.000 description 2
• 101710134056 Meprin A subunit beta Proteins 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• 102100023123 Mucin-16 Human genes 0.000 description 2
• 101710167853 N-methyltransferase Proteins 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 108091028043 Nucleic acid sequence Proteins 0.000 description 2
• 102100033357 Pancreatic lipase-related protein 2 Human genes 0.000 description 2
• 102000019280 Pancreatic lipases Human genes 0.000 description 2
• 108050006759 Pancreatic lipases Proteins 0.000 description 2
• 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
• 108010046644 Polymeric Immunoglobulin Receptors Proteins 0.000 description 2
• 102100035187 Polymeric immunoglobulin receptor Human genes 0.000 description 2
• 229920001213 Polysorbate 20 Polymers 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
• 206010036790 Productive cough Diseases 0.000 description 2
• 101710113029 Serine/threonine-protein kinase Proteins 0.000 description 2
• 102100025352 Serine/threonine-protein kinase MRCK alpha Human genes 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 238000002105 Southern blotting Methods 0.000 description 2
• 101710109667 Spectrin beta chain Proteins 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical class [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
• PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 108010046334 Urease Proteins 0.000 description 2
• 102100038364 Xaa-Pro aminopeptidase 2 Human genes 0.000 description 2
• 101710081950 Xaa-Pro aminopeptidase 2 Proteins 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 230000003187 abdominal effect Effects 0.000 description 2
• 230000021736 acetylation Effects 0.000 description 2
• 238000006640 acetylation reaction Methods 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 239000012491 analyte Substances 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 210000000941 bile Anatomy 0.000 description 2
• 210000000013 bile duct Anatomy 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 238000005251 capillar electrophoresis Methods 0.000 description 2
• 229940071704 cascara sagrada Drugs 0.000 description 2
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
• 210000003756 cervix mucus Anatomy 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• QBPFLULOKWLNNW-UHFFFAOYSA-N chrysazin Chemical compound O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O QBPFLULOKWLNNW-UHFFFAOYSA-N 0.000 description 2
• 210000001072 colon Anatomy 0.000 description 2
• 230000000112 colonic effect Effects 0.000 description 2
• 230000002860 competitive effect Effects 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 210000002808 connective tissue Anatomy 0.000 description 2
• 238000007405 data analysis Methods 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 231100000517 death Toxicity 0.000 description 2
• 230000017858 demethylation Effects 0.000 description 2
• 238000010520 demethylation reaction Methods 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 230000005750 disease progression Effects 0.000 description 2
• 239000000975 dye Substances 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 230000007717 exclusion Effects 0.000 description 2
• 238000000684 flow cytometry Methods 0.000 description 2
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 230000037406 food intake Effects 0.000 description 2
• 125000000524 functional group Chemical group 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 210000004907 gland Anatomy 0.000 description 2
• MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 2
• 229960004666 glucagon Drugs 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 238000009396 hybridization Methods 0.000 description 2
• 210000004408 hybridoma Anatomy 0.000 description 2
• 238000010166 immunofluorescence Methods 0.000 description 2
• 102000018358 immunoglobulin Human genes 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
• 229960000367 inositol Drugs 0.000 description 2
• 230000002452 interceptive effect Effects 0.000 description 2
• 230000009545 invasion Effects 0.000 description 2
• 229910052742 iron Inorganic materials 0.000 description 2
• 210000002429 large intestine Anatomy 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 230000033001 locomotion Effects 0.000 description 2
• 210000003750 lower gastrointestinal tract Anatomy 0.000 description 2
• 210000002751 lymph Anatomy 0.000 description 2
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
• 230000002438 mitochondrial effect Effects 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 230000000955 neuroendocrine Effects 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 238000003199 nucleic acid amplification method Methods 0.000 description 2
• 238000007899 nucleic acid hybridization Methods 0.000 description 2
• 201000004754 pancreatic intraductal papillary-mucinous neoplasm Diseases 0.000 description 2
• 229940116369 pancreatic lipase Drugs 0.000 description 2
• 208000021010 pancreatic neuroendocrine tumor Diseases 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
• 239000000049 pigment Substances 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• 239000004800 polyvinyl chloride Substances 0.000 description 2
• 229920000915 polyvinyl chloride Polymers 0.000 description 2
• 239000013641 positive control Substances 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• 235000019419 proteases Nutrition 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 210000000664 rectum Anatomy 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
• 210000003296 saliva Anatomy 0.000 description 2
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
• 210000000582 semen Anatomy 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• 210000004911 serous fluid Anatomy 0.000 description 2
• 210000003802 sputum Anatomy 0.000 description 2
• 208000024794 sputum Diseases 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 238000007619 statistical method Methods 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical group CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 238000012353 t test Methods 0.000 description 2
• 238000004809 thin layer chromatography Methods 0.000 description 2
• 230000001810 trypsinlike Effects 0.000 description 2
• 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 2
• 239000005483 tyrosine kinase inhibitor Substances 0.000 description 2
• 230000034512 ubiquitination Effects 0.000 description 2
• 238000010798 ubiquitination Methods 0.000 description 2
• 210000002438 upper gastrointestinal tract Anatomy 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 108010047303 von Willebrand Factor Proteins 0.000 description 2
• 102100036537 von Willebrand factor Human genes 0.000 description 2
• 229960001134 von willebrand factor Drugs 0.000 description 2
• CPUHNROBVJNNPW-VVBPCJSVSA-N (10r)-1,8-dihydroxy-3-(hydroxymethyl)-10-[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-10h-anthracen-9-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-VVBPCJSVSA-N 0.000 description 1
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical group NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
• AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
• 238000004780 2D liquid chromatography Methods 0.000 description 1
• OHXPGWPVLFPUSM-KLRNGDHRSA-N 3,7,12-trioxo-5beta-cholanic acid Chemical compound C1CC(=O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)C(=O)C[C@@H]3[C@]21C OHXPGWPVLFPUSM-KLRNGDHRSA-N 0.000 description 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
• XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
• YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
• GZAJOEGTZDUSKS-UHFFFAOYSA-N 5-aminofluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(N)=CC=C21 GZAJOEGTZDUSKS-UHFFFAOYSA-N 0.000 description 1
• ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
• 102300043138 A-kinase anchor protein 13 isoform 1 Human genes 0.000 description 1
• 102100040077 A-kinase anchor protein 6 Human genes 0.000 description 1
• 101710109923 A-kinase anchor protein 6 Proteins 0.000 description 1
• 102300057842 A-kinase anchor protein 9 isoform 2 Human genes 0.000 description 1
• 108050000246 AAA domains Proteins 0.000 description 1
• 230000005730 ADP ribosylation Effects 0.000 description 1
• 101150079978 AGRN gene Proteins 0.000 description 1
• 108091006112 ATPases Proteins 0.000 description 1
• 208000004998 Abdominal Pain Diseases 0.000 description 1
• 102300046070 Acetyl-CoA carboxylase 1 isoform 2 Human genes 0.000 description 1
• 102100021641 Acetyl-CoA carboxylase 2 Human genes 0.000 description 1
• 206010052747 Adenocarcinoma pancreas Diseases 0.000 description 1
• 206010001233 Adenoma benign Diseases 0.000 description 1
• 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 1
• 108010038310 Adenomatous polyposis coli protein Proteins 0.000 description 1
• 102100034534 Adenomatous polyposis coli protein 2 Human genes 0.000 description 1
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
• 102100036664 Adenosine deaminase Human genes 0.000 description 1
• 102100036799 Adhesion G-protein coupled receptor V1 Human genes 0.000 description 1
• 101710096099 Adhesion G-protein coupled receptor V1 Proteins 0.000 description 1
• 102100040026 Agrin Human genes 0.000 description 1
• 108700019743 Agrin Proteins 0.000 description 1
• 241001116389 Aloe Species 0.000 description 1
• 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
• 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
• 102100033804 Alpha-protein kinase 2 Human genes 0.000 description 1
• 101710082400 Alpha-protein kinase 2 Proteins 0.000 description 1
• 102100033806 Alpha-protein kinase 3 Human genes 0.000 description 1
• 101710082399 Alpha-protein kinase 3 Proteins 0.000 description 1
• 102100040191 Alpha-tectorin Human genes 0.000 description 1
• 101710114710 Alpha-tectorin Proteins 0.000 description 1
• 102100032360 Alstrom syndrome protein 1 Human genes 0.000 description 1
• 101710198494 Alstrom syndrome protein 1 Proteins 0.000 description 1
• 102100025981 Aminoacylase-1 Human genes 0.000 description 1
• 101710143180 Aminoacylase-1 Proteins 0.000 description 1
• 102100035765 Angiotensin-converting enzyme 2 Human genes 0.000 description 1
• 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 description 1
• 102100036818 Ankyrin-2 Human genes 0.000 description 1
• 101710191052 Ankyrin-2 Proteins 0.000 description 1
• 102300042762 Ankyrin-3 isoform 1 Human genes 0.000 description 1
• 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
• 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 108010014223 Armadillo Domain Proteins Proteins 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 230000003844 B-cell-activation Effects 0.000 description 1
• 108700020463 BRCA1 Proteins 0.000 description 1
• 102000036365 BRCA1 Human genes 0.000 description 1
• 102100037936 Basic helix-loop-helix domain-containing protein USF3 Human genes 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
• 108010018763 Biotin carboxylase Proteins 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 102000001805 Bromodomains Human genes 0.000 description 1
• 108050009021 Bromodomains Proteins 0.000 description 1
• 102100032955 C2 domain-containing protein 3 Human genes 0.000 description 1
• 101710186781 C2 domain-containing protein 3 Proteins 0.000 description 1
• 101710036791 CEP192 Proteins 0.000 description 1
• 102100024152 Cadherin-17 Human genes 0.000 description 1
• 101710196881 Cadherin-17 Proteins 0.000 description 1
• 102100035351 Cadherin-related family member 2 Human genes 0.000 description 1
• 101710148671 Cadherin-related family member 2 Proteins 0.000 description 1
• 102100035356 Cadherin-related family member 5 Human genes 0.000 description 1
• 101710148603 Cadherin-related family member 5 Proteins 0.000 description 1
• 241000345998 Calamus manan Species 0.000 description 1
• 102100039536 Calcium-activated chloride channel regulator 1 Human genes 0.000 description 1
• 101710186245 Calcium-activated chloride channel regulator 1 Proteins 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 102100022067 Cardiomyopathy-associated protein 5 Human genes 0.000 description 1
• 101710145118 Cardiomyopathy-associated protein 5 Proteins 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 102100028914 Catenin beta-1 Human genes 0.000 description 1
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
• 102100031456 Centriolin Human genes 0.000 description 1
• 101710109973 Centriolin Proteins 0.000 description 1
• 102100023344 Centromere protein F Human genes 0.000 description 1
• 102100025832 Centromere-associated protein E Human genes 0.000 description 1
• 101710105881 Centromere-associated protein E Proteins 0.000 description 1
• 102100036179 Centrosomal protein of 170 kDa Human genes 0.000 description 1
• 101710142011 Centrosomal protein of 170 kDa Proteins 0.000 description 1
• 102100036178 Centrosomal protein of 192 kDa Human genes 0.000 description 1
• 102100035696 Centrosome-associated protein 350 Human genes 0.000 description 1
• 101710101089 Centrosome-associated protein 350 Proteins 0.000 description 1
• 108010075016 Ceruloplasmin Proteins 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 108010062745 Chloride Channels Proteins 0.000 description 1
• 102000011045 Chloride Channels Human genes 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical class [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 102100023336 Chymotrypsin-like elastase family member 3B Human genes 0.000 description 1
• 101710149662 Chymotrypsin-like elastase family member 3B Proteins 0.000 description 1
• 108010038061 Chymotrypsinogen Proteins 0.000 description 1
• 101710178550 Chymotrypsinogen B2 Proteins 0.000 description 1
• 102100023331 Cilia- and flagella-associated protein 43 Human genes 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical class [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 102100023708 Coiled-coil domain-containing protein 80 Human genes 0.000 description 1
• 101710149102 Coiled-coil domain-containing protein 80 Proteins 0.000 description 1
• 102000000503 Collagen Type II Human genes 0.000 description 1
• 108010041390 Collagen Type II Proteins 0.000 description 1
• 102000001187 Collagen Type III Human genes 0.000 description 1
• 108010069502 Collagen Type III Proteins 0.000 description 1
• 102000004510 Collagen Type VII Human genes 0.000 description 1
• 108010017377 Collagen Type VII Proteins 0.000 description 1
• 102000009736 Collagen Type XI Human genes 0.000 description 1
• 108010034789 Collagen Type XI Proteins 0.000 description 1
• 102000014870 Collagen Type XII Human genes 0.000 description 1
• 108010039001 Collagen Type XII Proteins 0.000 description 1
• 102100033601 Collagen alpha-1(I) chain Human genes 0.000 description 1
• 102100031160 Collagen alpha-1(XX) chain Human genes 0.000 description 1
• 101710170735 Collagen alpha-1(XX) chain Proteins 0.000 description 1
• 102100037296 Collagen alpha-1(XXII) chain Human genes 0.000 description 1
• 101710085539 Collagen alpha-1(XXII) chain Proteins 0.000 description 1
• 102100036213 Collagen alpha-2(I) chain Human genes 0.000 description 1
• 101710126238 Collagen alpha-2(I) chain Proteins 0.000 description 1
• 102100024344 Collagen alpha-5(VI) chain Human genes 0.000 description 1
• 101710130002 Collagen alpha-5(VI) chain Proteins 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 108010028780 Complement C3 Proteins 0.000 description 1
• 102000016918 Complement C3 Human genes 0.000 description 1
• 108010053085 Complement Factor H Proteins 0.000 description 1
• 102100035432 Complement factor H Human genes 0.000 description 1
• 101800001847 Core protein precursor Proteins 0.000 description 1
• 241000938605 Crocodylia Species 0.000 description 1
• JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
• 102100031096 Cubilin Human genes 0.000 description 1
• 102100031635 Cytoplasmic dynein 1 heavy chain 1 Human genes 0.000 description 1
• 101710204897 Cytoplasmic dynein 1 heavy chain 1 Proteins 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 102100028216 DNA polymerase zeta catalytic subunit Human genes 0.000 description 1
• 101710161368 DNA polymerase zeta catalytic subunit Proteins 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 102100033589 DNA topoisomerase 2-beta Human genes 0.000 description 1
• 101710199063 DNA topoisomerase 2-beta Proteins 0.000 description 1
• 108010006124 DNA-Activated Protein Kinase Proteins 0.000 description 1
• 102000005768 DNA-Activated Protein Kinase Human genes 0.000 description 1
• 241000289632 Dasypodidae Species 0.000 description 1
• 102100031598 Dedicator of cytokinesis protein 1 Human genes 0.000 description 1
• 101710113370 Dedicator of cytokinesis protein 1 Proteins 0.000 description 1
• 102100024352 Dedicator of cytokinesis protein 4 Human genes 0.000 description 1
• 101710113364 Dedicator of cytokinesis protein 4 Proteins 0.000 description 1
• 102100024354 Dedicator of cytokinesis protein 6 Human genes 0.000 description 1
• 101710113361 Dedicator of cytokinesis protein 6 Proteins 0.000 description 1
• 102100024351 Dedicator of cytokinesis protein 7 Human genes 0.000 description 1
• 101710113362 Dedicator of cytokinesis protein 7 Proteins 0.000 description 1
• 102100031262 Deleted in malignant brain tumors 1 protein Human genes 0.000 description 1
• 102300064809 Deleted in malignant brain tumors 1 protein isoform 2 Human genes 0.000 description 1
• 102100038199 Desmoplakin Human genes 0.000 description 1
• 108091000074 Desmoplakin Proteins 0.000 description 1
• 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 1
• 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 1
• 102100035372 DmX-like protein 1 Human genes 0.000 description 1
• 101710105856 DmX-like protein 1 Proteins 0.000 description 1
• 102300064477 DmX-like protein 2 isoform 2 Human genes 0.000 description 1
• 102100034109 DnaJ homolog subfamily C member 13 Human genes 0.000 description 1
• 101710086618 DnaJ homolog subfamily C member 13 Proteins 0.000 description 1
• 201000010374 Down Syndrome Diseases 0.000 description 1
• 102100031648 Dynein axonemal heavy chain 5 Human genes 0.000 description 1
• 102100038912 E3 SUMO-protein ligase RanBP2 Human genes 0.000 description 1
• 101710198453 E3 SUMO-protein ligase RanBP2 Proteins 0.000 description 1
• 102100034677 E3 ubiquitin-protein ligase HECTD1 Human genes 0.000 description 1
• 101710091557 E3 ubiquitin-protein ligase HECTD1 Proteins 0.000 description 1
• 102100034745 E3 ubiquitin-protein ligase HERC2 Human genes 0.000 description 1
• 101710144727 E3 ubiquitin-protein ligase HERC2 Proteins 0.000 description 1
• 102100034893 E3 ubiquitin-protein ligase HUWE1 Human genes 0.000 description 1
• 101710157675 E3 ubiquitin-protein ligase HUWE1 Proteins 0.000 description 1
• 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 description 1
• 102100027418 E3 ubiquitin-protein ligase RNF213 Human genes 0.000 description 1
• 101710157159 E3 ubiquitin-protein ligase RNF213 Proteins 0.000 description 1
• 102100028093 E3 ubiquitin-protein ligase TRIP12 Human genes 0.000 description 1
• 102100029211 E3 ubiquitin-protein ligase TTC3 Human genes 0.000 description 1
• 101710148712 E3 ubiquitin-protein ligase TTC3 Proteins 0.000 description 1
• 102100037238 E3 ubiquitin-protein ligase UBR4 Human genes 0.000 description 1
• 101710188196 E3 ubiquitin-protein ligase UBR4 Proteins 0.000 description 1
• 102100040341 E3 ubiquitin-protein ligase UBR5 Human genes 0.000 description 1
• 101710188202 E3 ubiquitin-protein ligase UBR5 Proteins 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 241000792859 Enema Species 0.000 description 1
• 102000034258 Envoplakin Human genes 0.000 description 1
• 108010011042 Envoplakin Proteins 0.000 description 1
• 102100036443 Epiplakin Human genes 0.000 description 1
• 101710171298 Epiplakin Proteins 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 102100039254 Exophilin-5 Human genes 0.000 description 1
• 101710199477 Exophilin-5 Proteins 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 238000004252 FT/ICR mass spectrometry Methods 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 102100031509 Fibrillin-1 Human genes 0.000 description 1
• 108010030229 Fibrillin-1 Proteins 0.000 description 1
• 102300060193 Fibrocystin isoform 1 Human genes 0.000 description 1
• 102100030831 Fibrocystin-L Human genes 0.000 description 1
• 101710089769 Fibrocystin-L Proteins 0.000 description 1
• 102100037362 Fibronectin Human genes 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 102100027625 Fibrous sheath-interacting protein 2 Human genes 0.000 description 1
• 101710107040 Fibrous sheath-interacting protein 2 Proteins 0.000 description 1
• 102000013366 Filamin Human genes 0.000 description 1
• 108060002900 Filamin Proteins 0.000 description 1
• 102300043066 Filamin-A isoform 1 Human genes 0.000 description 1
• 102300043144 Filamin-B isoform 1 Human genes 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102000030782 GTP binding Human genes 0.000 description 1
• 108091000058 GTP-Binding Proteins 0.000 description 1
• 102100040510 Galectin-3-binding protein Human genes 0.000 description 1
• 101710197901 Galectin-3-binding protein Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 102400000921 Gastrin Human genes 0.000 description 1
• 108010052343 Gastrins Proteins 0.000 description 1
• 102000013382 Gelatinases Human genes 0.000 description 1
• 108010026132 Gelatinases Proteins 0.000 description 1
• 108010058940 Glutamyl Aminopeptidase Proteins 0.000 description 1
• 102000006485 Glutamyl Aminopeptidase Human genes 0.000 description 1
• 101710181600 Glycoprotein gp2 Proteins 0.000 description 1
• 108060003393 Granulin Proteins 0.000 description 1
• 102100028484 HEAT repeat-containing protein 5B Human genes 0.000 description 1
• 101710086424 HEAT repeat-containing protein 5B Proteins 0.000 description 1
• 102300055598 Haptoglobin isoform 1 Human genes 0.000 description 1
• 102100031880 Helicase SRCAP Human genes 0.000 description 1
• 101710201175 Helicase SRCAP Proteins 0.000 description 1
• 102100028893 Hemicentin-1 Human genes 0.000 description 1
• 101710142180 Hemicentin-1 Proteins 0.000 description 1
• 102100034629 Hemopexin Human genes 0.000 description 1
• 108010026027 Hemopexin Proteins 0.000 description 1
• 229920002971 Heparan sulfate Polymers 0.000 description 1
• 102100027755 Histone-lysine N-methyltransferase 2C Human genes 0.000 description 1
• 102100026265 Histone-lysine N-methyltransferase ASH1L Human genes 0.000 description 1
• 102100032742 Histone-lysine N-methyltransferase SETD2 Human genes 0.000 description 1
• 108010033040 Histones Proteins 0.000 description 1
• 101000805924 Homo sapiens Basic helix-loop-helix domain-containing protein USF3 Proteins 0.000 description 1
• 101000907999 Homo sapiens Cilia- and flagella-associated protein 43 Proteins 0.000 description 1
• 101000844721 Homo sapiens Deleted in malignant brain tumors 1 protein Proteins 0.000 description 1
• 101000866368 Homo sapiens Dynein axonemal heavy chain 5 Proteins 0.000 description 1
• 101001008892 Homo sapiens Histone-lysine N-methyltransferase 2C Proteins 0.000 description 1
• 101000785963 Homo sapiens Histone-lysine N-methyltransferase ASH1L Proteins 0.000 description 1
• 101000654725 Homo sapiens Histone-lysine N-methyltransferase SETD2 Proteins 0.000 description 1
• 101001055314 Homo sapiens Immunoglobulin heavy constant alpha 2 Proteins 0.000 description 1
• 101000840257 Homo sapiens Immunoglobulin kappa constant Proteins 0.000 description 1
• 101001002508 Homo sapiens Immunoglobulin-binding protein 1 Proteins 0.000 description 1
• 101000834851 Homo sapiens KICSTOR complex protein SZT2 Proteins 0.000 description 1
• 101001050274 Homo sapiens Keratin, type I cytoskeletal 9 Proteins 0.000 description 1
• 101001036256 Homo sapiens Little elongation complex subunit 1 Proteins 0.000 description 1
• 101000578920 Homo sapiens Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 Proteins 0.000 description 1
• 101000934489 Homo sapiens Nucleosome-remodeling factor subunit BPTF Proteins 0.000 description 1
• 101000872514 Homo sapiens Probable E3 ubiquitin-protein ligase HERC1 Proteins 0.000 description 1
• 101001050220 Homo sapiens Proteasome adapter and scaffold protein ECM29 Proteins 0.000 description 1
• 101000652263 Homo sapiens Protein SOGA1 Proteins 0.000 description 1
• 101000596012 Homo sapiens Protein TASOR 2 Proteins 0.000 description 1
• 101000982057 Homo sapiens Unconventional myosin-XVI Proteins 0.000 description 1
• 101710156827 Hydrocephalus-inducing protein Proteins 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 101710158906 Ig alpha-1 chain C region Proteins 0.000 description 1
• 102100026103 IgGFc-binding protein Human genes 0.000 description 1
• 101710147387 IgGFc-binding protein Proteins 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 102100029571 Immunoglobulin J chain Human genes 0.000 description 1
• 101710132152 Immunoglobulin J chain Proteins 0.000 description 1
• 102100026217 Immunoglobulin heavy constant alpha 1 Human genes 0.000 description 1
• 102100026216 Immunoglobulin heavy constant alpha 2 Human genes 0.000 description 1
• 102100029572 Immunoglobulin kappa constant Human genes 0.000 description 1
• 102100021042 Immunoglobulin-binding protein 1 Human genes 0.000 description 1
• 108010034219 Insulin Receptor Substrate Proteins Proteins 0.000 description 1
• 102100025092 Insulin receptor substrate 2 Human genes 0.000 description 1
• 102100025494 Intersectin-1 Human genes 0.000 description 1
• 206010070999 Intraductal papillary mucinous neoplasm Diseases 0.000 description 1
• 208000009164 Islet Cell Adenoma Diseases 0.000 description 1
• 206010023126 Jaundice Diseases 0.000 description 1
• 102000058057 JmjC domain-containing Human genes 0.000 description 1
• 108700001203 JmjC domain-containing Proteins 0.000 description 1
• 101710024993 KIAA1109 Proteins 0.000 description 1
• 101710058882 KIAA1671 Proteins 0.000 description 1
• 101710042703 KIAA2026 Proteins 0.000 description 1
• 102100026895 KICSTOR complex protein SZT2 Human genes 0.000 description 1
• 102300053887 Kalirin isoform 1 Human genes 0.000 description 1
• 102100038297 Kallikrein-1 Human genes 0.000 description 1
• 101710176219 Kallikrein-1 Proteins 0.000 description 1
• 102100023129 Keratin, type I cytoskeletal 9 Human genes 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• 108010020437 Ki-67 Antigen Proteins 0.000 description 1
• 102100037695 Kinesin-like protein KIF26A Human genes 0.000 description 1
• 101710133688 Kinesin-like protein KIF26A Proteins 0.000 description 1
• 102100038405 Kinesin-like protein KIF27 Human genes 0.000 description 1
• 101710134355 Kinesin-like protein KIF27 Proteins 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical group C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 239000005551 L01XE03 - Erlotinib Substances 0.000 description 1
• 108010059801 Lactase-Phlorizin Hydrolase Proteins 0.000 description 1
• 102000007547 Laminin Human genes 0.000 description 1
• 102100022746 Laminin subunit alpha-1 Human genes 0.000 description 1
• 101710200522 Laminin subunit alpha-1 Proteins 0.000 description 1
• 102100022745 Laminin subunit alpha-2 Human genes 0.000 description 1
• 101710200519 Laminin subunit alpha-2 Proteins 0.000 description 1
• 102300051952 Laminin subunit alpha-3 isoform 1 Human genes 0.000 description 1
• 102100027450 Laminin subunit alpha-5 Human genes 0.000 description 1
• 101710200521 Laminin subunit alpha-5 Proteins 0.000 description 1
• 102100027454 Laminin subunit beta-2 Human genes 0.000 description 1
• 101710186336 Laminin subunit beta-2 Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 1
• 102100030635 Leukocyte elastase inhibitor Human genes 0.000 description 1
• 101710091916 Leukocyte elastase inhibitor Proteins 0.000 description 1
• 108700039553 Lipase-like Proteins 0.000 description 1
• 102000019298 Lipocalin Human genes 0.000 description 1
• 108050006654 Lipocalin Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000003820 Lipoxygenases Human genes 0.000 description 1
• 108090000128 Lipoxygenases Proteins 0.000 description 1
• 108010014691 Lithostathine Proteins 0.000 description 1
• 102000016997 Lithostathine Human genes 0.000 description 1
• 102100027361 Lithostathine-1-alpha Human genes 0.000 description 1
• 101710160939 Lithostathine-1-alpha Proteins 0.000 description 1
• 102100039423 Little elongation complex subunit 1 Human genes 0.000 description 1
• 101710191762 Lysine-N-methylase Proteins 0.000 description 1
• 102100037611 Lysophospholipase Human genes 0.000 description 1
• 102100033472 Lysosomal-trafficking regulator Human genes 0.000 description 1
• 101710117316 Lysosomal-trafficking regulator Proteins 0.000 description 1
• 102300054914 MAX gene-associated protein isoform 1 Human genes 0.000 description 1
• 108091007877 MYCBP2 Proteins 0.000 description 1
• 102100030776 Matrix-remodeling-associated protein 5 Human genes 0.000 description 1
• 101710195820 Matrix-remodeling-associated protein 5 Proteins 0.000 description 1
• 102100022465 Methanethiol oxidase Human genes 0.000 description 1
• 101710134383 Methanethiol oxidase Proteins 0.000 description 1
• 102100021292 Methyl-CpG-binding domain protein 5 Human genes 0.000 description 1
• 101710111911 Methyl-CpG-binding domain protein 5 Proteins 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 102000002151 Microfilament Proteins Human genes 0.000 description 1
• 108010040897 Microfilament Proteins Proteins 0.000 description 1
• 102100028322 Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 Human genes 0.000 description 1
• 102100027666 Midasin Human genes 0.000 description 1
• 101710166824 Midasin Proteins 0.000 description 1
• 102100026285 Msx2-interacting protein Human genes 0.000 description 1
• 101710186687 Msx2-interacting protein Proteins 0.000 description 1
• 102100023124 Mucin-13 Human genes 0.000 description 1
• 101710155074 Mucin-13 Proteins 0.000 description 1
• 102100022494 Mucin-5B Human genes 0.000 description 1
• 108010030201 Mucin-5B Proteins 0.000 description 1
• 102100021286 Multiple PDZ domain protein Human genes 0.000 description 1
• 101710093002 Multiple PDZ domain protein Proteins 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101100518501 Mus musculus Spp1 gene Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 102300065422 Myomegalin isoform 9 Human genes 0.000 description 1
• 102100032971 Myomesin-1 Human genes 0.000 description 1
• 101710106571 Myomesin-1 Proteins 0.000 description 1
• 102300051166 Myosin-10 isoform 1 Human genes 0.000 description 1
• 102100033013 Myosin-13 Human genes 0.000 description 1
• 101710115161 Myosin-13 Proteins 0.000 description 1
• 102100032973 Myosin-15 Human genes 0.000 description 1
• 101710115138 Myosin-15 Proteins 0.000 description 1
• 102100038317 Myosin-3 Human genes 0.000 description 1
• 101710204040 Myosin-3 Proteins 0.000 description 1
• 102100038302 Myosin-4 Human genes 0.000 description 1
• 101710204042 Myosin-4 Proteins 0.000 description 1
• 102100038319 Myosin-6 Human genes 0.000 description 1
• 101710204027 Myosin-6 Proteins 0.000 description 1
• 102100038322 Myosin-7B Human genes 0.000 description 1
• 101710112039 Myosin-7B Proteins 0.000 description 1
• 102100038938 Myosin-9 Human genes 0.000 description 1
• 101710204108 Myosin-9 Proteins 0.000 description 1
• 102100040604 Myotubularin-related protein 5 Human genes 0.000 description 1
• 108050003253 Myotubularin-related protein 5 Proteins 0.000 description 1
• HRNLUBSXIHFDHP-UHFFFAOYSA-N N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide Chemical compound NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC1=NC=CC(C=2C=NC=CC=2)=N1 HRNLUBSXIHFDHP-UHFFFAOYSA-N 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• 102100031820 Na(+)/H(+) exchange regulatory cofactor NHE-RF4 Human genes 0.000 description 1
• 101710143585 Na(+)/H(+) exchange regulatory cofactor NHE-RF4 Proteins 0.000 description 1
• 239000007832 Na2SO4 Substances 0.000 description 1
• 102100031811 Nance-Horan syndrome protein Human genes 0.000 description 1
• 101710185889 Nance-Horan syndrome protein Proteins 0.000 description 1
• 102300050794 Nebulin isoform 1 Human genes 0.000 description 1
• 102300050796 Nebulin isoform 3 Human genes 0.000 description 1
• 102300037827 Nesprin-1 isoform 1 Human genes 0.000 description 1
• 102300037846 Nesprin-2 isoform 5 Human genes 0.000 description 1
• 102300053554 Neurobeachin isoform 1 Human genes 0.000 description 1
• 102000007530 Neurofibromin 1 Human genes 0.000 description 1
• 108010085793 Neurofibromin 1 Proteins 0.000 description 1
• 102300033917 Neuron navigator 1 isoform 1 Human genes 0.000 description 1
• 102300056114 Ninein isoform 2 Human genes 0.000 description 1
• 102100036961 Nuclear mitotic apparatus protein 1 Human genes 0.000 description 1
• 101710104794 Nuclear mitotic apparatus protein 1 Proteins 0.000 description 1
• 102300059691 Nuclear receptor corepressor 2 isoform 3 Human genes 0.000 description 1
• 102100025062 Nucleosome-remodeling factor subunit BPTF Human genes 0.000 description 1
• 102100030127 Obscurin Human genes 0.000 description 1
• 101710194880 Obscurin Proteins 0.000 description 1
• 102300055829 Obscurin-like protein 1 isoform 1 Human genes 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 102000016774 Otoferlin Human genes 0.000 description 1
• 108050006335 Otoferlin Proteins 0.000 description 1
• 102300033641 Otogelin isoform 1 Human genes 0.000 description 1
• 101710201636 PDZ domain-containing protein 2 Proteins 0.000 description 1
• 208000000407 Pancreatic Cyst Diseases 0.000 description 1
• 206010049082 Pancreatic mass Diseases 0.000 description 1
• 206010033645 Pancreatitis Diseases 0.000 description 1
• 102100033496 Partitioning defective 3 homolog Human genes 0.000 description 1
• 101710186509 Partitioning defective 3 homolog Proteins 0.000 description 1
• 102100039176 Pecanex-like protein 1 Human genes 0.000 description 1
• 101710115894 Pecanex-like protein 1 Proteins 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 102100024315 Pericentrin Human genes 0.000 description 1
• 101710179262 Pericentrin Proteins 0.000 description 1
• 101710095344 Pericentriolar material 1 protein Proteins 0.000 description 1
• 102100033422 Pericentriolar material 1 protein Human genes 0.000 description 1
• 241000009328 Perro Species 0.000 description 1
• 102100040402 Phlorizin hydrolase Human genes 0.000 description 1
• 108010058864 Phospholipases A2 Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 102100030477 Plectin Human genes 0.000 description 1
• 108010054050 Plectin Proteins 0.000 description 1
• 102300054671 Plexin-A4 isoform 1 Human genes 0.000 description 1
• 102300054748 Polycystin-1 isoform 2 Human genes 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 108010071690 Prealbumin Proteins 0.000 description 1
• 102000007584 Prealbumin Human genes 0.000 description 1
• 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
• 102100034747 Probable E3 ubiquitin-protein ligase HERC1 Human genes 0.000 description 1
• 102100021191 Probable G-protein coupled receptor 179 Human genes 0.000 description 1
• 108091011158 Probable G-protein coupled receptor 179 Proteins 0.000 description 1
• 102100027178 Probable helicase senataxin Human genes 0.000 description 1
• 101710205629 Probable helicase senataxin Proteins 0.000 description 1
• 102100034836 Proliferation marker protein Ki-67 Human genes 0.000 description 1
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
• 102100023080 Proteasome adapter and scaffold protein ECM29 Human genes 0.000 description 1
• 101800001072 Protein 1A Proteins 0.000 description 1
• 101800001064 Protein 2C Proteins 0.000 description 1
• 102100031838 Protein AHNAK2 Human genes 0.000 description 1
• 101710164032 Protein AHNAK2 Proteins 0.000 description 1
• 102100038589 Protein Daple Human genes 0.000 description 1
• 101710137182 Protein Daple Proteins 0.000 description 1
• 102100037113 Protein ELYS Human genes 0.000 description 1
• 101710086535 Protein ELYS Proteins 0.000 description 1
• 101710107800 Protein FAM186A Proteins 0.000 description 1
• 102100023820 Protein FAM186A Human genes 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 102100033954 Protein PRRC2A Human genes 0.000 description 1
• 101710130886 Protein PRRC2A Proteins 0.000 description 1
• 102100033953 Protein PRRC2B Human genes 0.000 description 1
• 101710130883 Protein PRRC2B Proteins 0.000 description 1
• 102100030527 Protein SOGA1 Human genes 0.000 description 1
• 102100031747 Protein Shroom3 Human genes 0.000 description 1
• 101710193120 Protein Shroom3 Proteins 0.000 description 1
• 102100035171 Protein TASOR 2 Human genes 0.000 description 1
• 102100025364 Protein bassoon Human genes 0.000 description 1
• 101710157359 Protein bassoon Proteins 0.000 description 1
• 102100029929 Protein dopey-2 Human genes 0.000 description 1
• 101710184529 Protein dopey-2 Proteins 0.000 description 1
• 101710131028 Protein furry homolog Proteins 0.000 description 1
• 102100020918 Protein furry homolog Human genes 0.000 description 1
• 101710201797 Protein furry homolog-like Proteins 0.000 description 1
• 102100020916 Protein furry homolog-like Human genes 0.000 description 1
• 101710092482 Protein kinase 4 Proteins 0.000 description 1
• 102100039154 Protein piccolo Human genes 0.000 description 1
• 101710140996 Protein piccolo Proteins 0.000 description 1
• 102300035191 Protein sidekick-1 isoform 1 Human genes 0.000 description 1
• 102100027897 Protein unc-13 homolog B Human genes 0.000 description 1
• 101710141054 Protein unc-13 homolog B Proteins 0.000 description 1
• 102100027900 Protein unc-13 homolog C Human genes 0.000 description 1
• 101710141053 Protein unc-13 homolog C Proteins 0.000 description 1
• 102100029474 Protein unc-79 homolog Human genes 0.000 description 1
• 101710182067 Protein unc-79 homolog Proteins 0.000 description 1
• 241000932156 Proteinus Species 0.000 description 1
• 108010067787 Proteoglycans Proteins 0.000 description 1
• 102000016611 Proteoglycans Human genes 0.000 description 1
• 108010026552 Proteome Proteins 0.000 description 1
• 102100022095 Protocadherin Fat 1 Human genes 0.000 description 1
• 101710095128 Protocadherin Fat 1 Proteins 0.000 description 1
• 102100022093 Protocadherin Fat 2 Human genes 0.000 description 1
• 101710095100 Protocadherin Fat 2 Proteins 0.000 description 1
• 102100022134 Protocadherin Fat 3 Human genes 0.000 description 1
• 101710095095 Protocadherin Fat 3 Proteins 0.000 description 1
• 102100034547 Protocadherin Fat 4 Human genes 0.000 description 1
• 101710095094 Protocadherin Fat 4 Proteins 0.000 description 1
• 102100036393 Protocadherin-16 Human genes 0.000 description 1
• 101710158009 Protocadherin-16 Proteins 0.000 description 1
• 102300061965 Protocadherin-23 isoform 1 Human genes 0.000 description 1
• 102000009609 Pyrophosphatases Human genes 0.000 description 1
• 108010009413 Pyrophosphatases Proteins 0.000 description 1
• 102100024694 Reelin Human genes 0.000 description 1
• 108700038365 Reelin Proteins 0.000 description 1
• 108010053823 Rho Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
• 102100032198 Rootletin Human genes 0.000 description 1
• 101710175555 Rootletin Proteins 0.000 description 1
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
• 102000019027 Ryanodine Receptor Calcium Release Channel Human genes 0.000 description 1
• 108010012219 Ryanodine Receptor Calcium Release Channel Proteins 0.000 description 1
• 102300059554 Ryanodine receptor 1 isoform 2 Human genes 0.000 description 1
• 102300059541 Ryanodine receptor 3 isoform 1 Human genes 0.000 description 1
• 108010010180 SCO-spondin Proteins 0.000 description 1
• 102100027296 SCO-spondin Human genes 0.000 description 1
• 102100032741 SET-binding protein Human genes 0.000 description 1
• 101710194492 SET-binding protein Proteins 0.000 description 1
• 101100348089 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) BUR6 gene Proteins 0.000 description 1
• 102100034272 Sacsin Human genes 0.000 description 1
• 101710102928 Sacsin Proteins 0.000 description 1
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
• 101710132826 Selenium-binding protein 1 Proteins 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 102100020824 Serine-protein kinase ATM Human genes 0.000 description 1
• 101710128348 Serine-protein kinase ATM Proteins 0.000 description 1
• 102100023921 Serine/threonine-protein kinase ATR Human genes 0.000 description 1
• 101710178061 Serine/threonine-protein kinase ATR Proteins 0.000 description 1
• 102100029938 Serine/threonine-protein kinase SMG1 Human genes 0.000 description 1
• 101710085356 Serine/threonine-protein kinase SMG1 Proteins 0.000 description 1
• 102100025512 Serpin B6 Human genes 0.000 description 1
• 102100026756 StAR-related lipid transfer protein 9 Human genes 0.000 description 1
• 101710139913 StAR-related lipid transfer protein 9 Proteins 0.000 description 1
• 102100024470 Stabilin-2 Human genes 0.000 description 1
• 101710164033 Stabilin-2 Proteins 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 102300037792 Supervillin isoform 2 Human genes 0.000 description 1
• 230000006044 T cell activation Effects 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 102100036855 TRIO and F-actin-binding protein Human genes 0.000 description 1
• 101710158845 TRIO and F-actin-binding protein Proteins 0.000 description 1
• 108091007076 TRIP12 Proteins 0.000 description 1
• 102100036977 Talin-1 Human genes 0.000 description 1
• 101710142287 Talin-1 Proteins 0.000 description 1
• 102100036980 Talin-2 Human genes 0.000 description 1
• 101710142305 Talin-2 Proteins 0.000 description 1
• 101710192266 Tegument protein VP22 Proteins 0.000 description 1
• 101710103331 Telomere-associated protein RIF1 Proteins 0.000 description 1
• 102100037806 Telomere-associated protein RIF1 Human genes 0.000 description 1
• 102100024549 Tenascin-X Human genes 0.000 description 1
• 102100033227 Teneurin-2 Human genes 0.000 description 1
• 101710122316 Teneurin-2 Proteins 0.000 description 1
• 102100038123 Teneurin-4 Human genes 0.000 description 1
• 101710122302 Teneurin-4 Proteins 0.000 description 1
• 102100031744 Tetratricopeptide repeat protein 28 Human genes 0.000 description 1
• 101710129209 Tetratricopeptide repeat protein 28 Proteins 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Chemical group CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Chemical group 0.000 description 1
• 101710120037 Toxin CcdB Proteins 0.000 description 1
• 102000002463 Transcription Factor TFIIIB Human genes 0.000 description 1
• 108010068071 Transcription Factor TFIIIB Proteins 0.000 description 1
• 102100028438 Transcription factor HIVEP2 Human genes 0.000 description 1
• 101710177553 Transcription factor HIVEP2 Proteins 0.000 description 1
• 102100023931 Transcriptional regulator ATRX Human genes 0.000 description 1
• 101710113296 Transcriptional regulator ATRX Proteins 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 102100025378 Transmembrane protein KIAA1109 Human genes 0.000 description 1
• 102100028569 Transport and Golgi organization protein 1 homolog Human genes 0.000 description 1
• 101710191185 Transport and Golgi organization protein 1 homolog Proteins 0.000 description 1
• 102300063548 Triosephosphate isomerase isoform 2 Human genes 0.000 description 1
• 102100028101 Triple functional domain protein Human genes 0.000 description 1
• 101710161296 Triple functional domain protein Proteins 0.000 description 1
• 102300063746 Trypsin-3 isoform 1 Human genes 0.000 description 1
• 102300063747 Trypsin-3 isoform 3 Human genes 0.000 description 1
• 102000000129 Tubulin polyglutamylase TTLL4 Human genes 0.000 description 1
• 108050008455 Tubulin polyglutamylase TTLL4 Proteins 0.000 description 1
• 101710098414 Tyrosine-protein phosphatase Proteins 0.000 description 1
• 102000006837 U5 Small Nuclear Ribonucleoprotein Human genes 0.000 description 1
• 108010086857 U5 Small Nuclear Ribonucleoprotein Proteins 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 102100037176 Ubiquitin carboxyl-terminal hydrolase 24 Human genes 0.000 description 1
• 101710091123 Ubiquitin carboxyl-terminal hydrolase 24 Proteins 0.000 description 1
• 101710141259 Uncharacterized protein C10 Proteins 0.000 description 1
• 102100022862 Uncharacterized protein KIAA1671 Human genes 0.000 description 1
• 102100022853 Uncharacterized protein KIAA2026 Human genes 0.000 description 1
• 102100026677 Unconventional myosin-XVI Human genes 0.000 description 1
• 102100037930 Usherin Human genes 0.000 description 1
• 101710138401 Usherin Proteins 0.000 description 1
• 108010075653 Utrophin Proteins 0.000 description 1
• 102100029092 Utrophin Human genes 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 229930003316 Vitamin D Natural products 0.000 description 1
• QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
• 102100036628 WD repeat-containing protein 87 Human genes 0.000 description 1
• 101710093189 WD repeat-containing protein 87 Proteins 0.000 description 1
• 102300057527 Xaa-Pro dipeptidase isoform 1 Human genes 0.000 description 1
• 101710180303 Zinc finger homeobox protein 2 Proteins 0.000 description 1
• 102100040033 Zinc finger homeobox protein 2 Human genes 0.000 description 1
• 102100039966 Zinc finger homeobox protein 3 Human genes 0.000 description 1
• 101710180292 Zinc finger homeobox protein 3 Proteins 0.000 description 1
• 102100039968 Zinc finger homeobox protein 4 Human genes 0.000 description 1
• 101710180302 Zinc finger homeobox protein 4 Proteins 0.000 description 1
• 102100028431 Zinc finger protein 292 Human genes 0.000 description 1
• 101710147076 Zinc finger protein 292 Proteins 0.000 description 1
• 102100029042 Zinc finger protein 469 Human genes 0.000 description 1
• 101710143702 Zinc finger protein 469 Proteins 0.000 description 1
• 102300064191 Zinc finger protein 638 isoform 1 Human genes 0.000 description 1
• 102100021144 Zinc-alpha-2-glycoprotein Human genes 0.000 description 1
• 101710201241 Zinc-alpha-2-glycoprotein Proteins 0.000 description 1
• UJIDKYTZIQTXPM-UHFFFAOYSA-N [4-[pyridin-2-yl-(4-sulfooxyphenyl)methyl]phenyl] hydrogen sulfate Chemical compound C1=CC(OS(=O)(=O)O)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS(O)(=O)=O)C=C1 UJIDKYTZIQTXPM-UHFFFAOYSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 238000004847 absorption spectroscopy Methods 0.000 description 1
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• 108010027140 adenomatous polyposis coli protein 2 Proteins 0.000 description 1
• 125000003172 aldehyde group Chemical group 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 235000011399 aloe vera Nutrition 0.000 description 1
• 108010091628 alpha 1-Antichymotrypsin Proteins 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 201000008266 amyotrophic lateral sclerosis type 2 Diseases 0.000 description 1
• 210000000436 anus Anatomy 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 230000010516 arginylation Effects 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 238000002820 assay format Methods 0.000 description 1
• 229940090047 auto-injector Drugs 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 230000001588 bifunctional effect Effects 0.000 description 1
• 239000003833 bile salt Substances 0.000 description 1
• 210000003445 biliary tract Anatomy 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 239000002981 blocking agent Substances 0.000 description 1
• 210000003995 blood forming stem cell Anatomy 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 239000008140 bowel preparation solution Substances 0.000 description 1
• KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 1
• JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 1
• WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 description 1
• JQVYZJIFFAHQKX-ZAULLPPESA-L calcium;3-carboxy-10-[2-carboxy-4-oxido-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracen-9-yl]-9-oxo-8-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-10h-anthracen-1-olate Chemical compound [Ca+2].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C([O-])=O)C=C1C2C1C2=CC(C([O-])=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 JQVYZJIFFAHQKX-ZAULLPPESA-L 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 230000023852 carbohydrate metabolic process Effects 0.000 description 1
• 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 229940071711 casanthranol Drugs 0.000 description 1
• 229940058505 cascara Drugs 0.000 description 1
• 239000004359 castor oil Substances 0.000 description 1
• 235000019438 castor oil Nutrition 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 210000004534 cecum Anatomy 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 108010031377 centromere protein F Proteins 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• SMNPLAKEGAEPJD-UHFFFAOYSA-N chembl34922 Chemical compound Cl.Cl.Cl.C1CN(C)CCN1C1=CC=C(NC(=N2)C=3C=C4N=C(NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 SMNPLAKEGAEPJD-UHFFFAOYSA-N 0.000 description 1
• AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 238000011260 co-administration Methods 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 238000002967 competitive immunoassay Methods 0.000 description 1
• 230000009918 complex formation Effects 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 229910001431 copper ion Inorganic materials 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000007797 corrosion Effects 0.000 description 1
• 238000005260 corrosion Methods 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 239000003431 cross linking reagent Substances 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 230000003436 cytoskeletal effect Effects 0.000 description 1
• 229960001577 dantron Drugs 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 229960002997 dehydrocholic acid Drugs 0.000 description 1
• 239000003398 denaturant Substances 0.000 description 1
• 238000000326 densiometry Methods 0.000 description 1
• 238000003795 desorption Methods 0.000 description 1
• 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
• 230000001079 digestive effect Effects 0.000 description 1
• 230000010339 dilation Effects 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 238000007598 dipping method Methods 0.000 description 1
• BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 102100030495 eIF-2-alpha kinase activator GCN1 Human genes 0.000 description 1
• 101710157028 eIF-2-alpha kinase activator GCN1 Proteins 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 238000011984 electrochemiluminescence immunoassay Methods 0.000 description 1
• 238000001493 electron microscopy Methods 0.000 description 1
• 238000002101 electrospray ionisation tandem mass spectrometry Methods 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 210000003890 endocrine cell Anatomy 0.000 description 1
• 238000012336 endoscopic ultrasonography Methods 0.000 description 1
• 238000001839 endoscopy Methods 0.000 description 1
• 239000007920 enema Substances 0.000 description 1
• 229940079360 enema for constipation Drugs 0.000 description 1
• 230000007515 enzymatic degradation Effects 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 239000002532 enzyme inhibitor Substances 0.000 description 1
• 238000011067 equilibration Methods 0.000 description 1
• AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 1
• 229960001433 erlotinib Drugs 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 210000003020 exocrine pancreas Anatomy 0.000 description 1
• 230000028023 exocytosis Effects 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 239000011152 fibreglass Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 238000004401 flow injection analysis Methods 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 235000012631 food intake Nutrition 0.000 description 1
• 238000005755 formation reaction Methods 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 230000006870 function Effects 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 230000006251 gamma-carboxylation Effects 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
• 125000003147 glycosyl group Chemical group 0.000 description 1
• 102000035122 glycosylated proteins Human genes 0.000 description 1
• 108091005608 glycosylated proteins Proteins 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 102000009543 guanyl-nucleotide exchange factor activity proteins Human genes 0.000 description 1
• 150000003278 haem Chemical group 0.000 description 1
• 230000005802 health problem Effects 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 230000033444 hydroxylation Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 239000000819 hypertonic solution Substances 0.000 description 1
• 229940021223 hypertonic solution Drugs 0.000 description 1
• 210000003405 ileum Anatomy 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 230000000984 immunochemical effect Effects 0.000 description 1
• 230000000951 immunodiffusion Effects 0.000 description 1
• 238000000760 immunoelectrophoresis Methods 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000013408 indirect enzyme-linked immunoassay Methods 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000004941 influx Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 108010079515 intersectin 1 Proteins 0.000 description 1
• 108010003082 intrinsic factor-cobalamin receptor Proteins 0.000 description 1
• 201000010985 invasive ductal carcinoma Diseases 0.000 description 1
• 230000026045 iodination Effects 0.000 description 1
• 238000006192 iodination reaction Methods 0.000 description 1
• 238000004255 ion exchange chromatography Methods 0.000 description 1
• 238000000534 ion trap mass spectrometry Methods 0.000 description 1
• 230000002262 irrigation Effects 0.000 description 1
• 238000003973 irrigation Methods 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 210000001630 jejunum Anatomy 0.000 description 1
• 208000032799 juvenile amyotrophic lateral sclerosis type 2 Diseases 0.000 description 1
• 238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• RVPVRDXYQKGNMQ-UHFFFAOYSA-N lead(2+) Chemical compound [Pb+2] RVPVRDXYQKGNMQ-UHFFFAOYSA-N 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 210000004901 leucine-rich repeat Anatomy 0.000 description 1
• 208000032839 leukemia Diseases 0.000 description 1
• 239000003591 leukocyte elastase inhibitor Substances 0.000 description 1
• 125000003473 lipid group Chemical group 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 210000004324 lymphatic system Anatomy 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• 239000006249 magnetic particle Substances 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 238000001819 mass spectrum Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
• 229910052753 mercury Inorganic materials 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 208000004141 microcephaly Diseases 0.000 description 1
• 238000000329 molecular dynamics simulation Methods 0.000 description 1
• 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
• 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
• 235000019799 monosodium phosphate Nutrition 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 229940030786 moviprep Drugs 0.000 description 1
• 238000000148 multi-dimensional chromatography Methods 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 230000007498 myristoylation Effects 0.000 description 1
• 210000002241 neurite Anatomy 0.000 description 1
• 210000003757 neuroblast Anatomy 0.000 description 1
• 201000002120 neuroendocrine carcinoma Diseases 0.000 description 1
• 201000011519 neuroendocrine tumor Diseases 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• 230000036963 noncompetitive effect Effects 0.000 description 1
• 231100001221 nontumorigenic Toxicity 0.000 description 1
• 239000012044 organic layer Substances 0.000 description 1
• 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
• 239000002357 osmotic agent Substances 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 201000002094 pancreatic adenocarcinoma Diseases 0.000 description 1
• 208000022102 pancreatic neuroendocrine neoplasm Diseases 0.000 description 1
• 238000005192 partition Methods 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 230000000858 peroxisomal effect Effects 0.000 description 1
• JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical class [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 108091005981 phosphorylated proteins Proteins 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 238000000711 polarimetry Methods 0.000 description 1
• 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000001103 potassium chloride Substances 0.000 description 1
• 235000011164 potassium chloride Nutrition 0.000 description 1
• 230000013823 prenylation Effects 0.000 description 1
• 239000002987 primer (paints) Substances 0.000 description 1
• 238000007639 printing Methods 0.000 description 1
• 230000002250 progressing effect Effects 0.000 description 1
• VYXXMAGSIYIYGD-NWAYQTQBSA-N propan-2-yl 2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(pyrimidine-4-carbonylamino)phosphoryl]amino]-2-methylpropanoate Chemical compound CC(C)OC(=O)C(C)(C)NP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)NC(=O)c1ccncn1 VYXXMAGSIYIYGD-NWAYQTQBSA-N 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 238000000751 protein extraction Methods 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 238000000164 protein isolation Methods 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 230000009145 protein modification Effects 0.000 description 1
• 230000006920 protein precipitation Effects 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 238000000734 protein sequencing Methods 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 229940043131 pyroglutamate Drugs 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• 230000006340 racemization Effects 0.000 description 1
• 235000012950 rattan cane Nutrition 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000006722 reduction reaction Methods 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 238000005096 rolling process Methods 0.000 description 1
• 239000011833 salt mixture Substances 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• 238000005070 sampling Methods 0.000 description 1
• 238000003345 scintillation counting Methods 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 210000004739 secretory vesicle Anatomy 0.000 description 1
• 239000011669 selenium Substances 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• 239000009814 sennoside A&B Substances 0.000 description 1
• 108010017282 serpin B6 Proteins 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 238000002798 spectrophotometry method Methods 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 238000012409 standard PCR amplification Methods 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 210000003699 striated muscle Anatomy 0.000 description 1
• 230000019635 sulfation Effects 0.000 description 1
• 238000005670 sulfation reaction Methods 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 210000002182 synaptic membrane Anatomy 0.000 description 1
• 108010020352 tenascin X Proteins 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 238000002366 time-of-flight method Methods 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 239000000439 tumor marker Substances 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Chemical group OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 210000005167 vascular cell Anatomy 0.000 description 1
• 230000002227 vasoactive effect Effects 0.000 description 1
• 235000019166 vitamin D Nutrition 0.000 description 1
• 239000011710 vitamin D Substances 0.000 description 1
• 150000003710 vitamin D derivatives Chemical class 0.000 description 1
• 229940046008 vitamin d Drugs 0.000 description 1
• 230000004580 weight loss Effects 0.000 description 1
• 208000016261 weight loss Diseases 0.000 description 1
• 238000010626 work up procedure Methods 0.000 description 1